China Resources Medical Holdings Company Limited
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offer… Read more
China Resources Medical Holdings Company Limited (1PH) - Total Assets
Latest total assets as of June 2025: €13.59 Billion EUR
Based on the latest financial reports, China Resources Medical Holdings Company Limited (1PH) holds total assets worth €13.59 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
China Resources Medical Holdings Company Limited - Total Assets Trend (2016–2024)
This chart illustrates how China Resources Medical Holdings Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
China Resources Medical Holdings Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
China Resources Medical Holdings Company Limited's total assets of €13.59 Billion consist of 24.3% current assets and 75.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 7.3% |
| Accounts Receivable | €1.64 Billion | 12.3% |
| Inventory | €301.66 Million | 2.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €7.78 Million | 0.1% |
| Goodwill | €3.60 Billion | 27.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how China Resources Medical Holdings Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China Resources Medical Holdings Company Limited's current assets represent 24.3% of total assets in 2024, a decrease from 25.7% in 2016.
- Cash Position: Cash and equivalents constituted 7.3% of total assets in 2024, down from 16.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, a decrease from 55.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 27.0% of total assets.
China Resources Medical Holdings Company Limited Competitors by Total Assets
Key competitors of China Resources Medical Holdings Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
China Resources Medical Holdings Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - China Resources Medical Holdings Company Limited generates 0.74x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, China Resources Medical Holdings Company Limited generates $ 4.25 in net profit.
China Resources Medical Holdings Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.74 | 0.86 | 2.05 |
| Quick Ratio | 0.68 | 0.79 | 2.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.21 Billion | € -587.19 Million | € 2.01 Billion |
China Resources Medical Holdings Company Limited - Advanced Valuation Insights
This section examines the relationship between China Resources Medical Holdings Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.53 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -2.5% |
| Total Assets | €13.32 Billion |
| Market Capitalization | $264.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values China Resources Medical Holdings Company Limited's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: China Resources Medical Holdings Company Limited's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for China Resources Medical Holdings Company Limited (2016–2024)
The table below shows the annual total assets of China Resources Medical Holdings Company Limited from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €13.32 Billion | -2.46% |
| 2023-12-31 | €13.65 Billion | +22.98% |
| 2022-12-31 | €11.10 Billion | +6.07% |
| 2021-12-31 | €10.47 Billion | +16.78% |
| 2020-12-31 | €8.96 Billion | +13.83% |
| 2019-12-31 | €7.87 Billion | +7.58% |
| 2018-12-31 | €7.32 Billion | +5.86% |
| 2017-12-31 | €6.91 Billion | +7.22% |
| 2016-12-31 | €6.45 Billion | -- |